Find Academic Supervisors

Roles and Affiliations Dr. Gregory Steinberg is a Professor in the Department of Medicine at McMaster University and Co-Director of the McMaster Centre for Metabolism, Obesity, and Diabetes Research. He holds the Canada Research Chair in Metabolism and Obesity and the J. Bruce Duncan Chair in Metabolic Diseases. His work bridges basic science and translational research, focusing on molecular mechanisms of metabolic diseases and their clinical applications. Research Interests His primary research explores molecular pathways controlling fat and sugar metabolism, with a focus on endocrine regulators like serotonin and GDF15. Key areas include: Metabolic signaling in obesity, diabetes, and cardiovascular disease Exercise and nutrition impacts on health Therapeutic strategies for metabolic disorders Role of AMPK in inflammation and energy homeostasis Recent studies highlight connections between adipose tissue, anxiety, and cancer biology, emphasizing interdisciplinary approaches to metabolic health. Key Awards and Recognition Recipient of prestigious awards such as the Canadian Institutes of Health Research Gold Leaf Prize and the American Diabetes Association Outstanding Scientific Achievement Award, underscoring his impactful contributions to metabolic research. Grants and Collaborations His lab has secured funding for projects investigating metabolic pathways in cancer, gut microbiome interactions, and novel therapeutic targets like AMPK activation. Collaborations span academia and industry, advancing drug development for obesity and diabetes. Labs and Teams Leads the Steinberg Lab at McMaster, part of the Department of Medicine and the Michael G. DeGroote School of Medicine. The lab integrates cellular biology, genetics, and clinical studies to address metabolic diseases at molecular and systemic levels.

• Metabolism
• Diabetes
• Obesity
• +6 more

Dr. Rebecca Henry is an Assistant Professor in Pharmacology at the School of Biomolecular and Biomedical Science, University College Dublin, where she joined in 2024 as a Royal Society - SFI University Research Fellow. Previously, she held a lectureship position at the Department of Anatomy & Neuroscience, University College Cork starting in 2021. Her educational background includes: B.Sc. (Hons) in Physiology from the University of Galway (2011) Ph.D. from the University of Galway (2015), investigating pharmacological modulation of the endocannabinoid system on TLR-induced neuroinflammation Postdoctoral training at the Shock Trauma and Anesthesiology Research Center (STAR), University of Maryland, Baltimore Certificate in Teaching and Learning in Higher Education from University College Cork (2022-2023) Johns Hopkins/University of Maryland Baltimore Collaborative Teaching Fellowship Program (2020-2021) Dr. Henry's research focuses on the neuroimmune interplay between obesity and traumatic brain injury (TBI). Her Henry Lab investigates how pre-existing metabolic dysfunction affects TBI outcomes, with particular emphasis on: Therapeutic potential of anti-obesity drugs in co-morbid diet-induced obesity and TBI Impact of environmental factors (exercise, diet) on TBI outcomes in obese patients Bi-directional relationship between the brain and periphery in obesity-TBI comorbidity Sex differences in neuroimmune responses to TBI and implications for treatment Analysis of her recent publications (2020-2025) reveals a strong focus on neuroinflammation mechanisms following TBI, particularly examining how obesity exacerbates TBI outcomes through altered immune responses. Her work spans from basic molecular mechanisms to clinical implications, with increasing emphasis on translational approaches to improve TBI outcomes in metabolically compromised patients. Her notable scientific achievement includes: Royal Society - SFI University Research Fellowship Dr. Henry serves as a PhD thesis supervisor and co-supervisor at University College Dublin. She has secured research funding including the SFI grant 'Investigation of the role of the GDF-15/GFRAL signalling axis in mediating neuroprotective effects in the presence of co-morbid diet-induced obesity and TBI' (2024-2027). Her teaching philosophy emphasizes active learning strategies, small group learning, and empowering students to take ownership of their learning. She holds formal teaching qualifications from both University College Cork and the Johns Hopkins/University of Maryland Baltimore Collaborative Teaching Fellowship Program.

• Traumatic Brain Injury
• Neuroinflammation
• Obesity-TBI Comorbidity
• +4 more

Professor Keith Murphy is a leading academic at University College Dublin , affiliated with the School of Biomolecular and Biomedical Science and the Conway Institute . As head of the UCD Neurotherapeutics Research Group , he pioneers work on drug targets for neurological disorders. Professor of Neuropharmacology (2018–present) Co-Director, UCD Centre for Applied Neuroscience (2015–present) Theme Leader for Neuroscience Research (2011–present) His research spans drug addiction , schizophrenia , multiple sclerosis , and memory consolidation , utilizing animal models , in vivo gene editing , and proteomic analysis . Recent work on cocaine-induced neurodevelopmental damage and midkine's role in memory demonstrates his focus on synaptic plasticity mechanisms. Key scientific contributions include: 2006: Rafaelsen Scholarship for neuropharmacology research 2016: Discovery of REST as hypoxia-responsive repressor 2025: Groundbreaking prenatal cocaine organoid study As an educator , he coordinated modules like Advanced CNS Pharmacology and Professional Career Development , mentoring future biomedical scientists. Current grants include SFI funding (2024–2027) for GDF-15/GFRAL signaling research in neuroprotection.

• Neuropharmacology
• Neuroscience
• Neurodegenerative Diseases
• +8 more